Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More

Clinical Trial: Effectiveness Of Project EX: A Classroom-Based Smoking Prevention And Cessation Intervention Program

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895784) titled 'Effectiveness Of Project EX: A Classroom-Based Smoking Prevention And Cessation Interventio... Read More

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More

Bill to restrict diplomatic passports for advisers, state ministers rejectedPublished on: October 27, 2026 9:59 AM

Pakistan, Oct. 27 -- The Senate on Monday blocked a private member's bill seeking to withdraw the free-for-all issuance of diplomatic passports to ministers of state, advisers, special assistants and ... Read More

The NPL is on, but fans in Achham can't get a signal

Achham, Oct. 27 -- As Sudurpaschim Royals took on Lumbini Lions in the opening match of the third Nepal Premier League on Monday, the action at Kathmandu's TU International Cricket Ground was also dra... Read More

KFin Technologies shares: Jio Platforms IPO allotment finalisation impact or Q2 results rally? 6% jump today

New Delhi, Oct. 27 -- KFin Technologies shares jumped 6% on Tuesday, October 27, as investors assessed the company's September-quarter earnings and watched the finalisation of the Jio Platforms IPO al... Read More

"Higher-than-usual turnout in left strongholds": Netanyahu urges his supporters as Israel records high early poll turnout

Jerusalem, Oct. 27 -- Israeli Prime Minister Benjamin Netanyahu on Tuesday (local time) urged right-wing voters to cast their ballots, claiming that turnout was higher than usual in left-wing strongho... Read More

'CID', 'Aahat' producer BP Singh passes away after major heart attack, final rites on Wednesday

Mumbai, Oct. 27 -- Veteran producer-director BP Singh, best known for his work on popular TV shows like 'CID' and 'Aahat', has passed away, filmmaker Ashoke Pandit confirmed in an Instagram post. Acc... Read More

• ««
• «
• 1218
• 1219
• 1220
• 1221
• 1222
• 1223
• 1224
• 1225
• 1226
• 1227
• »
• »»